AU · Healthcare

Proteomics International Laboratories Ltd (PIQ)

Biotechnology

Proteomics International Laboratories Ltd (PIQ) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PIQ

P/E ratio

25.00

Proteomics International Laboratories Ltd (PIQ) — FAQ

What is PIQ's P/E ratio?

The price-to-earnings (P/E) ratio for Proteomics International Laboratories Ltd (PIQ) is 25.00 (data as of 2026-05-24).

Does Proteomics International Laboratories Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Proteomics International Laboratories Ltd (PIQ). Check the MyAverix Finance app for the latest dividend data.

What sector is Proteomics International Laboratories Ltd in?

Proteomics International Laboratories Ltd (PIQ) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PIQ listed on?

PIQ is listed on AU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)